Evaluation of Two Modified Cardiac Troponin I Enzyme Immunoassays
Authors:
- Cornelia HaugCHCornelia Haug
- Max G. BachemMBMax G. Bachem
- Holger WoehrleHWHolger Woehrle
- Martin HetzelMHMartin Hetzel
- Adolf GruenertAGAdolf Gruenert
- 26 January 2002
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 40 (8)
Abstract
One of the major challenges for manufacturers of troponin immunoassays is to optimize the low-end of the assays because diagnostic and therapeutic interventions are based on decreasing cutpoints. Recently published consensus documents of the European Society of Cardiology and the American College of Cardiology recommended the 99th percentile of a reference control group as cut-off for increased troponin I levels and suggested that imprecision at the 99th percentile for each assay should be < or = 10%. In this study, we have evaluated two newly modified cardiac troponin I (cTnI) enzyme immunoassays (Dimension cTnI assay, Dade Behring, Germany and AIA-PACK cTnI 2nd-Gen, Eurogenetics Tosoh, Belgium). With both assays all measured cTnI values in plasma and serum samples of apparently healthy volunteers were within the reference ranges given by the manufacturers. Intra-assay coefficients of variation of cTnI concentrations above the 99th percentile (given by the manufacturers) were below 17% and decreased with increasing cTnI concentrations. In most samples, the AIA-PACK cTnI assay yielded higher results; however, a close correlation between both assays was observed. Both tests exhibit acceptable overall performance, but (especially the Dimension cTnI assay) do not yet meet the above-mentioned precision in the low-end assay range. These data emphasize the need for cTnI assay standardization and for further optimization at clinical decision levels.Keywords
This publication has 8 references indexed in Scilit:
- Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial InfarctionEuropean Heart Journal, 2000
- It’s Time for a Change to a Troponin StandardCirculation, 2000
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJACC, 2000
- Applicability of Cardiac Troponin T and I for Early Risk Stratification in Unstable Coronary Artery DiseaseCirculation, 1997
- Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1996
- Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial IschemiaNew England Journal of Medicine, 1996
- Early Monitoring of Serum Cardiac Troponin I for Assessment of Coronary Reperfusion Following Thrombolytic TherapyAmerican Journal of Clinical Pathology, 1996
- The Prognostic Value of Serum Troponin T in Unstable AnginaNew England Journal of Medicine, 1992